Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf source : Www.precisionbiosciences.com save search
Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic ‘Off-the-Shelf’ CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $12.935 -0.96% -0.97% 26K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion is Highly Active in Subjects with Relapsed/Refractory B-Cell Malignancies
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $12.935 -0.96% -0.97% 26K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t cel t-cell
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.